Stool DNA Testing to Screen for Colorectal Cancer in the Medicare Population: A Cost-Effectiveness Analysis

BACKGROUND: Centers for Medicare and Medicaid Services (CMS) considered whether to reimburse stool DNA testing for colorectal cancer screening among Medicare enrollees. OBJECTIVE: To evaluate the conditions under which stool DNA testing could be cost-effective compared with the colorectal cancer scr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Lansdorp-Vogelaar, Iris, Kuntz, Karen M., Knudsen, Amy B., Wilschut, Janneke A., Zauber, Ann G., van Ballegooijen, Marjolein
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3578600/
https://ncbi.nlm.nih.gov/pubmed/20855801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1059/0003-4819-153-6-201009210-00004
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller